Anti-inflammatory Effect of Astaxanthin on the Sickness Behavior Induced by Diabetes Mellitus

Cellular and Molecular Neurobiology

Volumn 35, Issue 7, 2015, Pages 1027-1037

  Ying, Chang jiang ^a   Zhang, Fang ^a   Zhou, Xiao yan ^a   Hu, Xiao tong ^a   Chen, Jing ^a   Wen, Xiang ru ^a   Sun, Ying ^a   Zheng, Kui yang ^a   Tang, Ren xian ^a   Song, Yuan jian ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Astaxanthin; Cystathionine synthase; Diabetes; Inflammation

Indexed keywords

ASTAXANTHIN; CASPASE 3; CYSTATHIONINE BETA SYNTHASE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; STREPTOZOCIN; ANTIINFLAMMATORY AGENT; XANTHOPHYLL;

ABNORMAL BEHAVIOR; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BODY WEIGHT; CLOSED FIELD TEST; CONTROLLED STUDY; CORPUS CALLOSUM; DIABETES MELLITUS; DOWN REGULATION; EXPLORATORY BEHAVIOR TEST; FLUID INTAKE; FRONTAL CORTEX; ILLNESS BEHAVIOR; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WEIGHT CHANGE; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; ILLNESS BEHAVIOR; MALE; MICE; MICE, INBRED ICR; TREATMENT OUTCOME; XANTHOPHYLLS;

EID: 84942197427     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-015-0197-3     Document Type: Article

References (66)

1. Aksu I, Ates M, Baykara B et al (2012) Anxiety correlates to decreased blood and prefrontal cortex IGF-1 levels in streptozotocin induced diabetes. Neurosci Lett 531:176–181
2. Ambati RR, Phang SM, Ravi S et al (2014) Astaxanthin: sources, extraction, stability, biological activities and its commercial applications a review. Mar Drugs 12:128–152
3. 2S)-producing enzymes and capacity in chronic kidney disease. Nephrol Dial Transplant 27:498–504
4. 2S production in Parkinson’s disease gene knockout astrocytes. J Am Chem Soc 135:9915–9923
5. Chen ML, Chen CH (2007) Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex. J Psychiatr Res 41:57–62
6. Chen C, Wang Y, Zhang J et al (2014) Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice. Dis Model Mech 7:723–730
7. Choi K, Le T, McGuire J et al (2012) Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear. J Psychiatr Res 46:882–889
8. Chourbaji S, Urani A, Inta I et al (2006) IL-6 knock out mice exhibit resistance to stress-induced development of depression like behaviors. Neurobiol Dis 23:587–594
9. Damián JP, Acosta V, Da Cuña M et al (2014) Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim 63:277–287
10. Dong LY, Jin J, Lu G et al (2013) Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar Drug 11:960–974
11. El-Akabawy G, El-Kholy W (2014) Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats. Ann Anat 196:119–128
12. Enhamre-Brolin E, Carlsson A, Hallberg M et al (2013) Growth hormone reverses streptozotocin-induced cognitive impairments in male mice. Behav Brain Res 238:273–278
13. Fu YY, Zhang F, Zhang L et al (2014) Mangiferin regulates interleukin-6 and cystathionine-b-synthase in lipopolysaccharide-induced brain injury. Cell Mol Neurobiol 34:651–657
14. Gibney SM, McGuinness B, Prendergast C et al (2013) Poly I:C-inducedactivation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain Behav Immun 28:170–181
15. Giuliani D, Ottani A, Zaffe D et al (2013) Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms. Neurobiol Learn Mem 104:82–91
16. Gong QH, Shi XR, Hong ZY et al (2011) A new hope for neurodegeneration: possible role of hydrogen sulfide. J Alzheimers Dis 24:173–182
17. Harden LM, du Plessis I, Roth J et al (2011) Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-1β and prostanoids inmediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology 36:608–622
18. Holmes C, Cunningham C, Zotova E et al (2011) Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology 77:212–218
19. Ishigami M, Hiraki K, Umemura K et al (2009) A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal 11:205–214
20. Ishiki M, Nishida Y, Ishibashi H et al (2013) Impact of divergent effects of astaxanthin on insulin signaling in L6 cells. Endocrinology 154:2600–2612
21. Jing YH, Chen KH, Kuo PC et al (2013) Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology 98:116–127
22. Katon W (2010) Depression and diabetes: unhealthy bedfellows. Depress Anxiety 27:323–326
23. Katon WJ, Young BA, Russo J et al (2013) Associat-ion of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med 11:245–250
24. Keleshian VL, Modi HR, Rapoport SI et al (2013) Aging is associated with altered inflammatory, arachidonic acid cascade, and synaptic markers, influenced by epigenetic modifications, in the human frontal cortex. J Neurochem 125:63–73
25. Kidd P (2011) Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev 16:355–364
26. Kim YJ, Kim YA, Yokozawa T (2009) Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J Aqric Food Chem 57:8793–8797
27. Kimura Y, Dargusch R, Schubert D (2006) Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 8:661–670
28. Kleinridders A, Ferris HA, Cai W et al (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63:2232–2243
29. Lindahl B (2008) An illness behavior view on coping with diabetes. Int J Behav Med 15:165–166
30. Liu YW, Zhu X, Yang QQ et al (2013) Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats. Psychopharmacology 228:585–594
31. Liu YW, Zhu X, Zhang L et al (2014) Cerebroprotective effects of ibuprofen on diabetic encephalopathy in rats. Pharmacol Biochem Behav 117:128–136
32. Lu YP, Liu SY, Sun H et al (2010) Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res 1360:40–48
33. Marin DP, Bolin AP, Macedo Rde C et al (2011) ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int Immunopharmacol 11:103–109
34. Marrero D, Pan Q, Barrett-Connor E et al (2014) Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res 23:75–88
35. Meng XF, Wang XL, Tian XJ et al (2014) Nod-like receptor protein 1 inflammasome mediates neuron injury under high glucose. Mol Neurobiol 49:673–684
36. O’Connor JC, Satpathy A, Hartman ME et al (2005) IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol 174:4991–4997
37. Ola MS, Aleisa AM, Al-Rejaie SS et al (2014) Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 35:1003–1008
38. Patel SS, Udayabanu M (2014) Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice. Metab Brain Dis 29:121–130
39. Petrak F, Herpertz S, Stridde E et al (2013) Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin. Diabetes Technol Ther 15:703–711
40. Qu K, Lee SW, Bian JS et al (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52:155–165
41. Rajashree R, Kholkute SD, Goudar SS (2011) Effects of duration of diabetes on behavioural and cognitive parameters in streptozotocin-induced juvenilediabetic rats. Malays J Med Sci 18:26–31
42. Renner NA, Sansing HA, Inglis FM et al (2013) Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes. J Cell Physiol 228:1284–1294
43. Ridderinkhof KR, Ullsperger M, Crone EA et al (2004) The role of the medial frontal cortex in cognitive control. Science 306:443–447
44. Saavedra JM (2012) Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell Mol Neurobiol 32:667–681
45. Sajatovic M, Dawson NV, Perzynski AT et al (2011) Best practices: optimizing care for people with serious mental illness and comorbid diabetes. Psychiatr Serv 62:1001–1003
46. Sharma AN, Elased KM, Garrett TL et al (2010) Neurobehavioral deficits in db/db diabetic mice. Physiol Behav 101:381–388
47. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M et al (2011) Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 16:751–762
48. Silverman MN, Mukhopadhyay P, Belyavskaya E et al (2013) Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Mol Psychiatry 18:1006–1017
49. Sima AA (2010) Encephalopathies: the emerging diabetic complications. Acta Diabetol 47:279–293
50. Sima AA, Zhang W, Kreipke CW et al (2009) Inflammation in diabetic encephalopathy is prevented by C-peptide. Rev Diabet Stud 6:37–42
51. 2S biogenesis via alternative trans-sulfuration reactions. J Biol Chem 284:22457–22466
52. Speranza L, Pesce M, Patruno A et al (2012) Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar Drug 10:890–899
53. Spulber S, Edoff K, Hong L et al (2012) Molecular hydrogen reduces LPS-induced neuroinflammation and promotes recovery from sickness behaviour in mice. PLoS ONE 7:e42078
54. Takao K, Kobayashi K, Hagihara H et al (2013) Deficiency of schnurri-2, an MHC enhancer binding protein, induces mild chronic inflammation in the brain andconfers molecular, neuronal, and behavioral phenotypes related to schizophrenia. Neuropsychopharmacology 38:1409–1425
55. Talaei F, Van Praag VM, Shishavan MH et al (2014) Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide. BMC Cell Biol 15:1–16
56. Tezuka T, Tamura M, Kondo MA et al (2013) Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis. Neurobiol Dis 59:63–68
57. Tomassoni D, Nwankwo IE, Gabrielli MG et al (2013) Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. Neurosci Lett 543:136–141
58. Tripathi DN, Jena GB (2008) Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. Toxicology 248:96–103
59. Wang HN, Wang L, Zhang RG et al (2014) Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoidsystem. J Psychiatr Res 51:79–87
60. Wiliński B, Wiliński J, Somogyi E et al (2013) Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacol Rep 65:737–742
61. Wu TH, Lin CH (2008) IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res 193:183–191
62. Yuan JP, Peng J, Yin K et al (2011) Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res 55:150–165
63. Zhang X, Bian JS (2014) Hydrogen sulfide: a neuromodulator and neuroprotectant in the central central nervous system. ACS Chem Neurosci 5:876–883
64. Zhang M, Shan H, Wang Y et al (2013a) The expression changes of cystathionine-β-synthase in brain cortex after traumatic brain injury. J Mol Neurosci 51:57–67
65. Zhang M, Shan H, Wang T et al (2013b) Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice. Neurochem Res 38:714–725
66. Zhang Q, Yuan L, Liu D et al (2014) Hydrogen sulfide attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation. Pharmacol Res 84:32–44